0

(±)-PD 128,907 hydrochloride

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP112960164
CAS112960-16-4
Structure
MDL NumberMFCD00210210
Molecular Weight285.77
InChI KeyDCFXOTRONMKUJB-QMDUSEKHSA-N
Descriptionsolid, ≥98% (HPLC)
SolubilityH2O: >5 mg/mL
Assay≥98% (HPLC)
Colorwhite
Formsolid
Size5MG, 25MG
1

Characterization of Unconditioned Behavioral Effects of Dopamine D3/D2 Receptor Agonists

B Geter-Douglass, J L Katz, K Alling, J B Acri, J M Witkin

J Pharmacol Exp Ther. 1997 Oct;283(1):7-15.

PMID: 9336302

1

Dopamine D(1) Receptor-Mediated Control of Striatal Acetylcholine Release by Endogenous Dopamine

E Acquas, G Di Chiara

Eur J Pharmacol. 1999 Oct 27;383(2):121-7.

PMID: 10585525

1

Dopamine D1- And D2-like Receptor Mechanisms in Relapse to Cocaine-Seeking Behavior: Effects of Selective Antagonists and Agonists

T V Khroyan, R L Barrett-Larimore, J K Rowlett, R D Spealman

J Pharmacol Exp Ther. 2000 Aug;294(2):680-7.

PMID: 10900248

1

Dopaminergic D2-like Agonists Produce Yawning in the Myelin Mutant Taiep and Sprague-Dawley Rats

Jose R Eguibar, Ma del Carmen Cortes, Manuel Lara-Lozano, Diana M Mendiola

Pharmacol Biochem Behav. 2012 Jul;102(1):118-23.

PMID: 22497991

1

Effects of Dopamine D1 Receptor Full Agonists in Rats Trained to Discriminate SKF 38393

S D Gleason, J M Witkin

Behav Pharmacol. 2004 Feb;15(1):85-9.

PMID: 15075630

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode